nodes	percent_of_prediction	percent_of_DWPC	metapath
Flupentixol—DDC—Circadian rythm related genes—TNFRSF11A—bone cancer	0.0354	0.0354	CbGpPWpGaD
Flupentixol—DDC—Tryptophan metabolism—CYP3A4—bone cancer	0.0354	0.0354	CbGpPWpGaD
Flupentixol—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.035	0.035	CbGpPWpGaD
Flupentixol—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.0328	0.0328	CbGpPWpGaD
Flupentixol—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.0327	0.0327	CbGpPWpGaD
Flupentixol—DRD2—Hypothetical Network for Drug Addiction—GRM1—bone cancer	0.0319	0.0319	CbGpPWpGaD
Flupentixol—HTR2A—SIDS Susceptibility Pathways—FEV—bone cancer	0.0261	0.0261	CbGpPWpGaD
Flupentixol—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.0191	0.0191	CbGpPWpGaD
Flupentixol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.0188	0.0188	CbGpPWpGaD
Flupentixol—DRD1—Circadian rythm related genes—TNFRSF11A—bone cancer	0.0185	0.0185	CbGpPWpGaD
Flupentixol—DDC—Tryptophan metabolism—MDM2—bone cancer	0.0163	0.0163	CbGpPWpGaD
Flupentixol—DRD2—Circadian rythm related genes—TNFRSF11A—bone cancer	0.014	0.014	CbGpPWpGaD
Flupentixol—CHRM1—Circadian rythm related genes—TNFRSF11A—bone cancer	0.0137	0.0137	CbGpPWpGaD
Flupentixol—HTR2A—GPCRs, Other—GRM1—bone cancer	0.0136	0.0136	CbGpPWpGaD
Flupentixol—DDC—Circadian rythm related genes—GNA11—bone cancer	0.012	0.012	CbGpPWpGaD
Flupentixol—DDC—Circadian rythm related genes—EZH2—bone cancer	0.0119	0.0119	CbGpPWpGaD
Flupentixol—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.0115	0.0115	CbGpPWpGaD
Flupentixol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.011	0.011	CbGpPWpGaD
Flupentixol—CHRM1—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	0.0105	0.0105	CbGpPWpGaD
Flupentixol—ADRA1A—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	0.0104	0.0104	CbGpPWpGaD
Flupentixol—HTR2A—GPCRs, Other—SMO—bone cancer	0.00959	0.00959	CbGpPWpGaD
Flupentixol—HTR2A—G alpha (q) signalling events—GRM1—bone cancer	0.00765	0.00765	CbGpPWpGaD
Flupentixol—CHRM1—G alpha (q) signalling events—GRM1—bone cancer	0.00761	0.00761	CbGpPWpGaD
Flupentixol—ADRA1A—G alpha (q) signalling events—GRM1—bone cancer	0.00749	0.00749	CbGpPWpGaD
Flupentixol—DRD2—G alpha (i) signalling events—GRM4—bone cancer	0.00747	0.00747	CbGpPWpGaD
Flupentixol—DRD2—G alpha (i) signalling events—RGS1—bone cancer	0.00747	0.00747	CbGpPWpGaD
Flupentixol—DDC—Metabolism—NDUFA12—bone cancer	0.00738	0.00738	CbGpPWpGaD
Flupentixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—bone cancer	0.00684	0.00684	CbGpPWpGaD
Flupentixol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—bone cancer	0.00681	0.00681	CbGpPWpGaD
Flupentixol—DDC—Circadian rythm related genes—CDK4—bone cancer	0.00674	0.00674	CbGpPWpGaD
Flupentixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—bone cancer	0.0067	0.0067	CbGpPWpGaD
Flupentixol—DRD1—Circadian rythm related genes—GNA11—bone cancer	0.00626	0.00626	CbGpPWpGaD
Flupentixol—DRD1—Circadian rythm related genes—EZH2—bone cancer	0.00624	0.00624	CbGpPWpGaD
Flupentixol—DDC—Metabolism—NT5C3A—bone cancer	0.00612	0.00612	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—GRM4—bone cancer	0.00599	0.00599	CbGpPWpGaD
Flupentixol—CHRM1—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.00588	0.00588	CbGpPWpGaD
Flupentixol—ADRA1A—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.00579	0.00579	CbGpPWpGaD
Flupentixol—DDC—SIDS Susceptibility Pathways—JUN—bone cancer	0.00532	0.00532	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—GRM1—bone cancer	0.00519	0.00519	CbGpPWpGaD
Flupentixol—HTR2A—G alpha (q) signalling events—GNA11—bone cancer	0.00493	0.00493	CbGpPWpGaD
Flupentixol—CHRM1—G alpha (q) signalling events—GNA11—bone cancer	0.0049	0.0049	CbGpPWpGaD
Flupentixol—ADRA1A—G alpha (q) signalling events—GNA11—bone cancer	0.00483	0.00483	CbGpPWpGaD
Flupentixol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.00479	0.00479	CbGpPWpGaD
Flupentixol—DRD2—Circadian rythm related genes—GNA11—bone cancer	0.00473	0.00473	CbGpPWpGaD
Flupentixol—DRD2—Circadian rythm related genes—EZH2—bone cancer	0.00471	0.00471	CbGpPWpGaD
Flupentixol—CHRM1—Circadian rythm related genes—GNA11—bone cancer	0.00463	0.00463	CbGpPWpGaD
Flupentixol—CHRM1—Circadian rythm related genes—EZH2—bone cancer	0.00461	0.00461	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—GRM4—bone cancer	0.00452	0.00452	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—GRM4—bone cancer	0.00445	0.00445	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—GRM4—bone cancer	0.00443	0.00443	CbGpPWpGaD
Flupentixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.00441	0.00441	CbGpPWpGaD
Flupentixol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.00439	0.00439	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—GRM4—bone cancer	0.00436	0.00436	CbGpPWpGaD
Flupentixol—DDC—Circadian rythm related genes—JUN—bone cancer	0.00434	0.00434	CbGpPWpGaD
Flupentixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.00432	0.00432	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—GRM1—bone cancer	0.00392	0.00392	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.00392	0.00392	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—GRM1—bone cancer	0.00386	0.00386	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—GRM1—bone cancer	0.00384	0.00384	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—GRM1—bone cancer	0.00378	0.00378	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—SMO—bone cancer	0.00366	0.00366	CbGpPWpGaD
Flupentixol—DRD1—Circadian rythm related genes—CDK4—bone cancer	0.00352	0.00352	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—RGS1—bone cancer	0.00338	0.00338	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—GRM4—bone cancer	0.00338	0.00338	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.00333	0.00333	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—RGS1—bone cancer	0.00307	0.00307	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—GRM4—bone cancer	0.00307	0.00307	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.00304	0.00304	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—GRM1—bone cancer	0.00293	0.00293	CbGpPWpGaD
Flupentixol—CHRM1—Regulation of Actin Cytoskeleton—BRAF—bone cancer	0.00292	0.00292	CbGpPWpGaD
Flupentixol—DDC—Circadian rythm related genes—TP53—bone cancer	0.00287	0.00287	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.00276	0.00276	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—SMO—bone cancer	0.00276	0.00276	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.00273	0.00273	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—SMO—bone cancer	0.00272	0.00272	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—SMO—bone cancer	0.0027	0.0027	CbGpPWpGaD
Flupentixol—DDC—Metabolism—ENO2—bone cancer	0.00268	0.00268	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—GRM1—bone cancer	0.00267	0.00267	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—SMO—bone cancer	0.00266	0.00266	CbGpPWpGaD
Flupentixol—DRD2—Circadian rythm related genes—CDK4—bone cancer	0.00266	0.00266	CbGpPWpGaD
Flupentixol—CHRM1—Circadian rythm related genes—CDK4—bone cancer	0.0026	0.0026	CbGpPWpGaD
Flupentixol—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	0.00258	0.00258	CbGpPWpGaD
Flupentixol—ADRA1A—AMPK Signaling—TP53—bone cancer	0.00256	0.00256	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—GRM4—bone cancer	0.00256	0.00256	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—RGS1—bone cancer	0.00256	0.00256	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—GRM4—bone cancer	0.00251	0.00251	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—RGS1—bone cancer	0.00251	0.00251	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—GRM4—bone cancer	0.0025	0.0025	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—RGS1—bone cancer	0.0025	0.0025	CbGpPWpGaD
Flupentixol—DDC—Metabolism—DHFR—bone cancer	0.00249	0.00249	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—RGS1—bone cancer	0.00246	0.00246	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—GRM4—bone cancer	0.00246	0.00246	CbGpPWpGaD
Flupentixol—DDC—Metabolism—GNA11—bone cancer	0.00232	0.00232	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—GRM4—bone cancer	0.00232	0.00232	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—RGS1—bone cancer	0.00232	0.00232	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.00231	0.00231	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.0023	0.0023	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—GRM4—bone cancer	0.00228	0.00228	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—RGS1—bone cancer	0.00228	0.00228	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—GRM4—bone cancer	0.00227	0.00227	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—RGS1—bone cancer	0.00227	0.00227	CbGpPWpGaD
Flupentixol—DRD1—Circadian rythm related genes—JUN—bone cancer	0.00227	0.00227	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—GRM4—bone cancer	0.00224	0.00224	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—RGS1—bone cancer	0.00224	0.00224	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—GRM1—bone cancer	0.00222	0.00222	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—GRM1—bone cancer	0.00218	0.00218	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—GRM1—bone cancer	0.00217	0.00217	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—GRM1—bone cancer	0.00213	0.00213	CbGpPWpGaD
Flupentixol—DDC—Metabolism—CYP3A4—bone cancer	0.00211	0.00211	CbGpPWpGaD
Flupentixol—HTR2A—SIDS Susceptibility Pathways—JUN—bone cancer	0.00206	0.00206	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—GRM1—bone cancer	0.00201	0.00201	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00199	0.00199	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—GRM1—bone cancer	0.00198	0.00198	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—GRM1—bone cancer	0.00197	0.00197	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—GRM1—bone cancer	0.00194	0.00194	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—GNA11—bone cancer	0.00189	0.00189	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—SMO—bone cancer	0.00188	0.00188	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—GRM4—bone cancer	0.00182	0.00182	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—RGS1—bone cancer	0.00182	0.00182	CbGpPWpGaD
Flupentixol—DDC—Metabolism—GSTP1—bone cancer	0.0018	0.0018	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—NDUFA12—bone cancer	0.0018	0.0018	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—GNA11—bone cancer	0.00172	0.00172	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—IL3—bone cancer	0.00171	0.00171	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.00171	0.00171	CbGpPWpGaD
Flupentixol—DRD2—Circadian rythm related genes—JUN—bone cancer	0.00171	0.00171	CbGpPWpGaD
Flupentixol—CHRM1—Circadian rythm related genes—JUN—bone cancer	0.00168	0.00168	CbGpPWpGaD
Flupentixol—CHRM1—Regulation of Actin Cytoskeleton—EGFR—bone cancer	0.00167	0.00167	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—GRM1—bone cancer	0.00157	0.00157	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—IL3—bone cancer	0.00156	0.00156	CbGpPWpGaD
Flupentixol—DRD1—Circadian rythm related genes—TP53—bone cancer	0.0015	0.0015	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—NT5C3A—bone cancer	0.00149	0.00149	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—GNA11—bone cancer	0.00143	0.00143	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—SMO—bone cancer	0.00142	0.00142	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—GNA11—bone cancer	0.0014	0.0014	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—GNA11—bone cancer	0.0014	0.0014	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—SMO—bone cancer	0.00139	0.00139	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—SMO—bone cancer	0.00139	0.00139	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—GNA11—bone cancer	0.00138	0.00138	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—RGS1—bone cancer	0.00137	0.00137	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—GRM4—bone cancer	0.00137	0.00137	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—SMO—bone cancer	0.00137	0.00137	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—RGS1—bone cancer	0.00135	0.00135	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—GRM4—bone cancer	0.00135	0.00135	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—GRM4—bone cancer	0.00134	0.00134	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—RGS1—bone cancer	0.00134	0.00134	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—RGS1—bone cancer	0.00132	0.00132	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—GRM4—bone cancer	0.00132	0.00132	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—GNA11—bone cancer	0.0013	0.0013	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—IL3—bone cancer	0.00129	0.00129	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—GNA11—bone cancer	0.00128	0.00128	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—IL3—bone cancer	0.00127	0.00127	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.00127	0.00127	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—GNA11—bone cancer	0.00127	0.00127	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—IL3—bone cancer	0.00127	0.00127	CbGpPWpGaD
Flupentixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.00126	0.00126	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—GNA11—bone cancer	0.00125	0.00125	CbGpPWpGaD
Flupentixol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.00125	0.00125	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—IL3—bone cancer	0.00125	0.00125	CbGpPWpGaD
Flupentixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.00123	0.00123	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.00122	0.00122	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—GRM1—bone cancer	0.00119	0.00119	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—IL3—bone cancer	0.00118	0.00118	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—GRM1—bone cancer	0.00117	0.00117	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—GRM1—bone cancer	0.00116	0.00116	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—IL3—bone cancer	0.00116	0.00116	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—IL3—bone cancer	0.00115	0.00115	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—GRM1—bone cancer	0.00115	0.00115	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—IL3—bone cancer	0.00113	0.00113	CbGpPWpGaD
Flupentixol—DRD2—Circadian rythm related genes—TP53—bone cancer	0.00113	0.00113	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—SMO—bone cancer	0.00111	0.00111	CbGpPWpGaD
Flupentixol—CHRM1—Circadian rythm related genes—TP53—bone cancer	0.00111	0.00111	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.0011	0.0011	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—GNA11—bone cancer	0.00101	0.00101	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—ATF1—bone cancer	0.000943	0.000943	CbGpPWpGaD
Flupentixol—DDC—Metabolism—PTGS2—bone cancer	0.000934	0.000934	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—IL3—bone cancer	0.00092	0.00092	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000868	0.000868	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—SMO—bone cancer	0.000838	0.000838	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—SMO—bone cancer	0.000824	0.000824	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—SMO—bone cancer	0.00082	0.00082	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—SMO—bone cancer	0.000807	0.000807	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—TGFBR2—bone cancer	0.000787	0.000787	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—GNA11—bone cancer	0.000766	0.000766	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—GNA11—bone cancer	0.000754	0.000754	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—GNA11—bone cancer	0.00075	0.00075	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—IGF1R—bone cancer	0.00074	0.00074	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—GNA11—bone cancer	0.000738	0.000738	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000729	0.000729	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—ATF1—bone cancer	0.000712	0.000712	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—ATF1—bone cancer	0.000701	0.000701	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—ATF1—bone cancer	0.000697	0.000697	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—IL3—bone cancer	0.000694	0.000694	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—ATF1—bone cancer	0.000686	0.000686	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—IL3—bone cancer	0.000683	0.000683	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—IL3—bone cancer	0.00068	0.00068	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—IL3—bone cancer	0.000669	0.000669	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—ENO2—bone cancer	0.000654	0.000654	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—DHFR—bone cancer	0.000607	0.000607	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—TGFBR2—bone cancer	0.000594	0.000594	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—TGFBR2—bone cancer	0.000584	0.000584	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—TGFBR2—bone cancer	0.000581	0.000581	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	0.000572	0.000572	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—GNA11—bone cancer	0.000567	0.000567	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—IGF1R—bone cancer	0.000559	0.000559	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—IGF1R—bone cancer	0.00055	0.00055	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—IGF1R—bone cancer	0.000547	0.000547	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—IGF1R—bone cancer	0.000538	0.000538	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—KIT—bone cancer	0.000537	0.000537	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—CYP3A4—bone cancer	0.000514	0.000514	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—BRAF—bone cancer	0.000505	0.000505	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—EGFR—bone cancer	0.000489	0.000489	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—GSTP1—bone cancer	0.00044	0.00044	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—MDM2—bone cancer	0.000423	0.000423	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—KIT—bone cancer	0.000405	0.000405	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—KIT—bone cancer	0.000399	0.000399	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—KIT—bone cancer	0.000397	0.000397	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—KIT—bone cancer	0.00039	0.00039	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—BRAF—bone cancer	0.000381	0.000381	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—BRAF—bone cancer	0.000375	0.000375	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—BRAF—bone cancer	0.000373	0.000373	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—EGFR—bone cancer	0.000369	0.000369	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—JUN—bone cancer	0.000367	0.000367	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—BRAF—bone cancer	0.000367	0.000367	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—EGFR—bone cancer	0.000363	0.000363	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—EGFR—bone cancer	0.000361	0.000361	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—MMP9—bone cancer	0.000358	0.000358	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—EGFR—bone cancer	0.000356	0.000356	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—MDM2—bone cancer	0.000319	0.000319	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—MDM2—bone cancer	0.000314	0.000314	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—MDM2—bone cancer	0.000312	0.000312	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—MDM2—bone cancer	0.000308	0.000308	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—EGFR—bone cancer	0.000289	0.000289	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—JUN—bone cancer	0.000277	0.000277	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—JUN—bone cancer	0.000273	0.000273	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—JUN—bone cancer	0.000272	0.000272	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—MMP9—bone cancer	0.00027	0.00027	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—JUN—bone cancer	0.000267	0.000267	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—MMP9—bone cancer	0.000266	0.000266	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—MMP9—bone cancer	0.000264	0.000264	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—MMP9—bone cancer	0.00026	0.00026	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—TP53—bone cancer	0.000243	0.000243	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PTGS2—bone cancer	0.000228	0.000228	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—EGFR—bone cancer	0.000218	0.000218	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—EGFR—bone cancer	0.000215	0.000215	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—EGFR—bone cancer	0.000213	0.000213	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—EGFR—bone cancer	0.00021	0.00021	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—TP53—bone cancer	0.000183	0.000183	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—TP53—bone cancer	0.00018	0.00018	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—TP53—bone cancer	0.000179	0.000179	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—TP53—bone cancer	0.000176	0.000176	CbGpPWpGaD
